Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human

Cancer Gene Therapy

Volumn 15, Issue 4, 2008, Pages 225-230

  Khorsandi, S E ^a   Bachellier, P ^a,b   Weber, J C ^a,b   Greget, M ^b   Jaeck, D ^b   Zacharoulis, D ^c   Rountas, C ^c   Helmy, S ^a,d   Helmy, A ^d   Al Waracky, M ^d   Salama, H ^d   Jiao, L ^a   Nicholls, J ^a   Davies, A J ^a   Levicar, N ^a   Jensen, S ^a   Habib, N ^a,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c General Hospital   (Greece)

^d CAIRO UNIVERSITY   (Egypt)

^e HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Human; Hydrodynamic gene therapy; Pig

Indexed keywords

THROMBOPOIETIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BALLOON CATHETER; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG SELECTIVITY; FEMALE; GENE THERAPY; HUMAN; HYDRODYNAMICS BASED TRANSFECTION; LIVER; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANIMALS; FEMALE; GENE THERAPY; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLASMIDS; SWINE; THROMBOCYTOPENIA; THROMBOPOIETIN;

ANIMALIA; SUIDAE;

EID: 40549090572     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/sj.cgt.7701119     Document Type: Article

References (11)

1. Budker V, Zhang G, Knechtel S, Wolff JA. Naked DNA delivered intraportally expresses efficiently in hepatocytes. Gene Therapy 1996; 13: 593-598.
2. Liu F, Song YK, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258-1266.
3. Zhang G, Gao X, Song YK, Vollmer R, Stolz DB, Gasiorowski JZ et al. Hydroboration as the mechanism of hydrodynamic delivery. Gene Therapy 2004; 11: 675-682.
4. Kobayashi N, Nishikawa M, Hirata K, Takakura Y. Hydrodynamics-based procedure involves transient hyper-permeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 2004; 6: 584-592.
5. Andrianaivo F, Lecocq M, Wattiaux-De Coninck S, Wattiaux R, Jadot M. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J Gene Med 2004; 6: 877-883.
6. Crespo A, Peydro A, Dasi F, Benet M, Calvete JJ, Revert F, Alino SF. Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles. Gene Therapy 2005; 12: 927-937.
7. Miao CH, Thompson AR, Loeb K, Ye X. Long term transgene and therapeutic level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol Ther 2001; 3: 947-957.
8. Eastman SJ, Baskin KM, Hodges BL, Chu O, Gates A, Dreusike R et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065-2077.
9. Alino SF, Herrero MF, Noguera I, Dasi F, Sanchez M. Pig liver gene therapy by noninvasive interventionist catheterism. Gene Therapy 2007; 14: 334-343.
10. Yoshino H, Hashizume K, Kobayashi E. Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume. Gene Therapy 2006; 13: 1696-1702.
11. Habib N, Havlik R, Jiao L, Kiri A, Jensen S, Nicholls J et al. Combination of Optison™ with ultrasound and electroporation increases albumin and thrombopoietin transgene expression whilst elongation factor promoter prolongs its duration. Gene Ther Mol Biol 2004; 8: 1-7.